Clinical trial
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
NCT00315380 · University of Pennsylvania, Other · Recruiting
Key facts
| NCT number | NCT00315380 |
|---|---|
| Title | Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis |
| Official title | Longitudinal Protocol for Eosinophilic Granulomatosis With Polyangiitis |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | GlaxoSmithKline Industry AstraZeneca |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome |
| Enrollment | 700 |
| Start date | Apr 1, 2006 |
| Primary completion | Dec 1, 2028 |
| Completion | Dec 1, 2028 |
| First posted | Apr 18, 2006 |
| Last update posted | Jan 23, 2026 |
| Countries | Canada, Germany, Italy, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: